未找到相关数据
Atezolizumab plus Bevacizumab Followed by Curative Conversion (ABC Conversion) in Patients with Unresectable, TACE-Unsuitable Intermediate-Stage Hepatocellular Carcinoma
被引：50
作者：
Kudo, Masatoshi
[1
]
机构：
[1] Kindai Univ, Fac Med, Dept Gastroenterol & Hepatol, Osaka, Japan
关键词：
Atezolizumab plus bevacizumab;
Hepatocellular carcinoma;
ABC conversion;
Curative therapy;
Cancer-free status;
Drug-free status;
POSITRON-EMISSION-TOMOGRAPHY;
T-CELL RESPONSES;
RADIOFREQUENCY ABLATION;
F-18-FDG PET/CT;
TUMOR;
LENVATINIB;
DIFFERENTIATION;
IDENTIFICATION;
ENHANCEMENT;
MULTICENTER;
D O I：
10.1159/000526163
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：399 / 406
页数：8
相关论文